tiprankstipranks
Trending News
More News >
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market

Allarity Therapeutics (ALLR) Income Statement

Compare
285 Followers

Allarity Therapeutics Income Statement

Last quarter (Q1 2025), Allarity Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Allarity Therapeutics's net income was $-2.73M. See Allarity Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -37.00K$ -120.00K$ -106.00K$ -86.00K
Operating Expenses
$ 17.54M$ 17.89M$ 16.89M$ 26.56M$ 9.23M
Depreciation and Amortization
$ -1.69M$ 37.00K$ 120.00K$ 106.00K$ 86.00K
EBITDA
$ -27.24M$ -12.08M$ -17.24M$ -25.91M$ -6.01M
Operating Income
$ -27.24M$ -17.93M$ -34.46M$ -26.56M$ -9.23M
Other Income/Expenses
$ 2.35M$ 5.31M$ -687.00K$ 41.00K$ 1.90M
Pretax Income
$ -24.90M$ -12.62M$ -17.58M$ -26.52M$ -7.23M
Net Income
$ -24.52M$ -11.90M$ -16.06M$ -26.65M$ -5.07M
Per Share Metrics
Basic EPS
$ 0.00$ -0.01$ -1.86M$ -3.52M$ -1.70M
Diluted EPS
$ 0.00$ -0.01$ -1.86M$ -3.52M$ -1.70M
Weighted Average Shares Outstanding
1.58M 1.99M---
Weighted Average Shares Outstanding (Diluted)
1.58M 1.99M---
Currency in USD

Allarity Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis